Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Temple

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Clinical Therapeutics|January 4, 2011
Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
The AAPS Journal|May 5, 2010
Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified release products: workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2010
Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
Expert Review of Neurotherapeutics|February 25, 2015
Building a roadmap for developing combination therapies for Alzheimer's diseaseDaniel Perry, Reisa Sperling, Russell Katz, et al.
Circulation|January 30, 2020
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future DirectionsAbhinav Sharma, Neha J Pagidipati, Robert M Califf, et al.
JAMA Network Open|May 31, 2022
Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical TrialSean D Pokorney, Noelle Cocoros, Hussein R Al-Khalidi, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
Roadmap to 2030 for Drug Evaluation in Older AdultsQi Liu, Janice B Schwartz, Patricia W Slattum, et al.
Circulation|October 22, 2019
Technology-Enabled Clinical Trials: Transforming Medical Evidence GenerationGuillaume Marquis-Gravel, Matthew T Roe, Mintu P Turakhia, et al.
American Heart Journal|June 2, 2007
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policyGillian D Sanders, Sana M Al-Khatib, Elise Berliner, et al.
Journal of Clinical Pharmacology|April 2, 2008
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance processShiew-Mei Huang, John M Strong, Lei Zhang, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Clinical Therapeutics|January 4, 2011
Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
The AAPS Journal|May 5, 2010
Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified release products: workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2010
Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
Expert Review of Neurotherapeutics|February 25, 2015
Building a roadmap for developing combination therapies for Alzheimer's diseaseDaniel Perry, Reisa Sperling, Russell Katz, et al.
Circulation|January 30, 2020
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future DirectionsAbhinav Sharma, Neha J Pagidipati, Robert M Califf, et al.
JAMA Network Open|May 31, 2022
Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical TrialSean D Pokorney, Noelle Cocoros, Hussein R Al-Khalidi, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
Roadmap to 2030 for Drug Evaluation in Older AdultsQi Liu, Janice B Schwartz, Patricia W Slattum, et al.
Circulation|October 22, 2019
Technology-Enabled Clinical Trials: Transforming Medical Evidence GenerationGuillaume Marquis-Gravel, Matthew T Roe, Mintu P Turakhia, et al.
American Heart Journal|June 2, 2007
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policyGillian D Sanders, Sana M Al-Khatib, Elise Berliner, et al.
Journal of Clinical Pharmacology|April 2, 2008
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance processShiew-Mei Huang, John M Strong, Lei Zhang, et al.
Pageof 9